← Back
$RCUS All transactions

Arcus Biosciences, Inc.

M 10b5-1 Plan

$ Value

$0

Shares

12,500

Price

$0

Filed

Oct 8

Insider

Name

Jarrett Jennifer

Title

Chief Operating Officer

CIK

0001671311

Roles

Officer

Transaction Details

Transaction Date

2025-10-06

Code

M

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

168,666

Footnotes

The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. | Includes 863 shares purchased on 5/30/2025 through the Company's Employee Stock Purchase Plan. | The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.40 to $14.72, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. | The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.00 to $15.16, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. | The option is fully vested and currently exercisable.

Filing Info

Accession No.

0001671311-25-000003

Form Type

4

Issuer CIK

0001724521

Jarrett Jennifer's History

Date Ticker Type Value
2026-03-30 DMRA A $0
2026-03-30 DMRA A $0
2026-01-23 RCUS A $0
2026-01-23 RCUS A $0
2025-12-17 RCUS $221K
2025-12-16 RCUS $246K
2025-11-07 RCUS M $62K
2025-11-07 RCUS $954K
2025-11-07 RCUS M $62K
2025-10-08 RCUS M $46K

Other Insiders at RCUS (90d)

Insider Bought Sold Last
ROSEN TERRY J
Chief Executive Officer
2026-01-23
Jaen Juan C.
President
2026-01-23
Goeltz II Robert C.
Chief Financial Officer
2026-01-23
Jarrett Jennifer
Chief Operating Officer
2026-01-23
Azoy Alexander
Chief Accounting Officer
2026-01-23
Tang Carolyn C.
General Counsel
2026-01-23
Markus Richard
Chief Medical Officer
2026-01-23